1-12 of 12
Hiroshi Yagi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 216: HMGB1 regulates homing capacity of human mesenchymal stromal cells into colon cancer.

Go Hoshino, Hiroshi Yagi, Hirotoshi Hasegawa, Yoshiyuki Ishii, Takashi Endo, Koji Okabayashi, Akimasa Yasuda, Masaya Nakamura, Hideyuki Okano, Yumi Matsuzaki, Yuko Kitagawa
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 216.
https://doi.org/10.1158/1538-7445.AM2013-216
Published: 15 April 2013
View article titled, Abstract 216: HMGB1 regulates homing capacity of human mesenchymal stromal cells into colon cancer.
Journal Articles

Synergistic anti-tumor effects in combination of Gemcitabine with inhibitors for amphiregulin.

Tatsuya Fukami, Hiroshi Yagi, Fusanori Yotsumoto, Akihiro Funakoshi, Masahide Kuroki, Eisuke Mekada, Shingo Miyamoto
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3382.
Published: 01 May 2008
View article titled, Synergistic anti-tumor effects in combination of Gemcitabine with inhibitors for amphiregulin.
Journal Articles

Heparin-binding epidermal growth factor-like growth factor (HB) regulates mammary tumorigenesis through EGFR as well as Her2 signal

Fusanori Yotsumoto, Hiroshi Yagi, Tatsuya Fukami, Masahide Kuroki, Hiroto Mizushima, Eisuke Mekada, Shingo Miyamoto
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5175.
Published: 01 May 2008
View article titled, Heparin-binding epidermal growth factor-like growth factor (HB) regulates mammary tumorigenesis through EGFR as well as Her2 signal
Journal Articles

Blockade of HB-EGF induces synergistic anti-tumor effects with taxol in ovarian cancer.

Shingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, Kenzo Sonoda, Toru Hachisuga, Tatsuhiko Kawarabayashi, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1297–1298.
Published: 15 April 2006
View article titled, Blockade of HB-EGF induces synergistic anti-tumor effects with taxol in ovarian cancer.
Journal Articles

Heparin binding epidermal growth factor like growth factor (HB) is a promising target for human cancer therapy.

Fusanori Yotsumoto, Shingo Miyamoto, Hiroshi Yagi, Hiroshi Tsujioka, Toru Hachisuga, Tatsuhiko Kawarabayashi, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1296.
Published: 15 April 2006
View article titled, Heparin binding epidermal growth factor like growth factor (HB) is a promising target for human cancer therapy.
Journal Articles

HB-EGF involved in peritoneal implantation of ovarian cancer

Hiroshi Yagi, Shingo Miyamoto, Fusanori Yotsumoto, Hiroshi Tsujioka, Toru Hachisuga, Tatsuhiko Kawarabayashi, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 15.
Published: 15 April 2006
View article titled, HB-EGF involved in peritoneal implantation of ovarian cancer
Journal Articles

Inhibition of tumor growth by an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1.

Hiroshi Yagi, Masakazu Ueda, Hiromitsu Jinnno, Koichi Aiura, Masaharu Seno, Hiroko Tada, Hidenori Yamada, Masaki Kitajima
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1202.
Published: 15 April 2006
View article titled, Inhibition of tumor growth by an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1.
Journal Articles

Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy

Shingo Miyamoto, Michinari Hirata, Ayano Yamazaki, Takuya Kageyama, Hidetoshi Hasuwa, Hiroto Mizushima, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Masahiro Kai, Hideo Kanoh, Hitoo Nakano, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5720–5727.
https://doi.org/10.1158/0008-5472.CAN-04-0811
Published: 16 August 2004
View article titled, Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
Open the PDF for Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

The clinical significance of RCAS1 in uterine cancer patients

Kenzo Sonoda, Shingo Miyamoto, Manabu Nakashima, Hiroshi Yagi, Yoshihiro Tanaka, Takeshi Watanabe, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 440.
Published: 01 April 2004
View article titled, The clinical significance of RCAS1 in uterine cancer patients
Journal Articles

HB-EGF in ascites involved in tumor extension of ovarian cancer

Hiroshi Yagi, Shingo Miyamoto, Yoshihiro Tanaka, Kenzo Sonoda, Hiroaki Kobayashi, Eisuke Mekada, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1026.
Published: 01 April 2004
View article titled, HB-EGF in ascites involved in tumor extension of ovarian cancer
Journal Articles

The clinical significance of HB-EGF and ADAM12 expression in human ovarian cancer

Yoshihiro Tanaka, Shingo Miyamoto, Hiroshi Yagi, Kenzo Sonoda, Eiji Oki, Eisuke Mekada, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1029–1030.
Published: 01 April 2004
View article titled, The clinical significance of HB-EGF and ADAM12 expression in human ovarian cancer
Journal Articles

HB-EGF is a targeting molecule for the treatment of ovarian cancer

Shingo Miyamoto, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Hitoo Nakano, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1198.
Published: 01 April 2004
View article titled, HB-EGF is a targeting molecule for the treatment of ovarian cancer